Elite Pharmaceuticals Inc (ELTP)

[Pharma Sleuth]

If it is Vyanese but you also have to consider Concerta and Oxy and Adderall ER and unknown #3. It's still getting you to $9b market.

And it's still only guessing at 10% market share. Concerta could have only a few comps. I took low numbers across the board to make the point.

OXY we might be first to get approved.

Why I chose 10% because it's so low but the numbers are still massive.

Based on the fact we are marketing our own drugs and we are a small lean company, we most likely can be unbelievably price competitive. That's what is happening with the current drugs I suspect.

And again, these are the known knowns and the known unknowns.

You would have to assume that Elite was done developing more drugs after these 9b market which we know that is not the case.